The project will leverage an existing online survey tool that researchers have used to investigate risk factors for Alzheimer’s disease.
The United States Patent and Trademark Office (USPTO) has introduced a pilot program to provide prioritized patent examination for patent applications that cover a product or process related to COVID-19. The product or process must be subject to an applicable U.S. Food and Drug Administration (FDA) approval for COVID-19 use.Continue reading
Tucson, Ariz. – The University of Arizona and state of Arizona antibody testing initiative will include 31 sites across the state as it expands to all 15 counties.Continue reading
Sarah Arrowsmith, lab coordinator and scientist at Biodesign Institute Center for Environmental Biotechnology, stepped up to make coth masks for others. The team at the ASU Biodesign institute ran tests to determine how effective these homemade masks may be. Continue reading
- Testing – What is the difference between tests?
- Testing – Who needs it and when?
- Testing – How can we get the job done?
“This is not a green light to speed, this is a green light to proceed, and we are going to proceed with caution,” Arizona Governor Doug DuceyContinue reading
Washington, DC (May 12, 2020) – The Biotechnology Innovation Organization (BIO) today unveiled a first-of-its-kind, interactive tracker of the new treatments and vaccines in the COVID-19 pipeline. This online resource illustrates the unprecedented campaign being undertaken by biopharmaceutical innovators to combat – and ultimately eradicate – the novel coronavirus. Continue reading
- Unprecedented program convenes manufacturers and pharmacies to help millions of Americans access prescription medications at affordable and predictable prices
- Express Scripts Parachute RxSM will cap costs at $25 for a 30-day supply of generic drugs; $75 for a 30-day supply of brand-name medicines for a limited time
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced availability of a newly created “Code of Ethics Compliance Guidance Related to the COVID-19 Response.”
“This guidance seeks to help AdvaMed members and other medical technology companies develop and implement processes that both support rapid decision-making in the context of the pandemic and mitigate any related compliance risks,” said Christopher L. White, AdvaMed COVID action team leader, chief operating officer and general counsel.Continue reading
On January 20, 2019, AZBio hosted a thought leadership event at Barrett-Jackson Scottsdale featuring a panel discussion on Health Innovation with Dr. Anna Barker and Dr. George Poste. During the discussion, Dr. Poste, shared his thoughts on the need for governments and our industry to prepare for global pandemics and what the Bipartisan Commission on Biodefense had reported. Dr. Poste, an ex officio member of the commission, shared that is was not a matter of if a global pandemic would occur, but of when.
The first report of a COVID-19 case in the U.S. was January 20, 2020. Today, the world is learning more about what happens in a global pandemic than we ever wanted to know. And, we still have a lot more to learn.Continue reading